InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Aktis Oncology, Inc.

AKTS
United States Fiscal year ends December CIK 0002035832 Results filed 13 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Helen Susan Kim
12 Jan 2026
Director
Buy indirect
22,545
$18.00
$405.81K
Helen Susan Kim
12 Jan 2026
Director
Buy indirect
812,455
$18.00
$14.62M
Vida Ventures II, LLC
12 Jan 2026
10% owner
Buy indirect
22,545
$18.00
$405.81K
Vida Ventures II, LLC
12 Jan 2026
10% owner
Buy indirect
812,455
$18.00
$14.62M
EcoR1 Capital, LLC
12 Jan 2026
Director
Buy indirect
144,443
$18.00
$2.60M
EcoR1 Capital, LLC
12 Jan 2026
Director
Buy indirect
2,077,779
$18.00
$37.40M
Ansbert Gadicke
12 Jan 2026
10% owner
Buy indirect
1,112,777
$18.00
$20.03M
Mpm Bioventures 2018, L.p.
12 Jan 2026
10% owner
Buy indirect
1,112,777
$18.00
$20.03M
Todd Foley
12 Jan 2026
Director
Buy indirect
232,870
$18.00
$4.19M
Show all 20 transactions →

What was left out

Form 4 filings counted 13
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 11
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 34,344,412
History held since 12 Jan 2026